Freenome, Inc. Investment Income, Dividend
Freenome, Inc. (FRNM) reported Investment Income, Dividend of $487.56 thousand for the 3-month period ending 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2026-08-18
- Freenome, Inc. investment income, dividend for the quarter ending 2026-06-30 was $487.56K.
- Freenome, Inc. investment income, dividend for the quarter ending 2025-06-30 was $0.00.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month |
|---|---|---|
| 2026-06-30 | $487.56K S-1 · filed 2026-08-18 | $487.56K S-1 · filed 2026-08-18 |
| 2025-06-30 | $0.00 S-1 · filed 2026-08-18 | $0.00 S-1 · filed 2026-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |